Company
ChinaHaimen Pharma Co., Ltd., Nantong, China – FDA Inspections
Inspection records and compliance data for Haimen Pharma Co., Ltd. in Nantong. 4 FDA inspections on record, 2 Form 483s, last inspected August 25, 2023.
Company Profile
This profile covers Haimen Pharma Co., Ltd. based in Nantong, China.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 2
- Warning letters
- 0
First inspected September 8, 2017. Last inspected August 25, 2023.
Most cited issue areas
- Habits of good sanitation & health1 inspection
- Written record of investigation incomplete1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 25, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1254733 |
| January 10, 2020 | NAI | Human Drugs · Drug Quality Assurance | 1115958 |
| January 12, 2019 | VAI | Human Drugs · Generic Drug Evaluation | 1078088 |
| September 8, 2017 | Not classified | Human Drugs | 1027385 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Zhejiang Yongtai Pharmaceutical Co. Ltd
Hainan Simcere Pharmaceutical Co., Ltd.
Novast Laboratories Ltd.
Hangzhou Solipharma Co., Ltd.
Viwit Pharmaceutical Co., Ltd.
Bostal Drug Delivery Co., Ltd.
OP NanoPharma Co., Ltd. Yunlin Plant
Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road)
Simcere Pharmaceutical Co., Ltd.
Company Information
Name
Haimen Pharma Co., Ltd.
FEI Number
3011266110
Address
No. 163 Zhuhai Rd, Binjiang Street, Haimen District, Nantong, China
Country
China
ID: de674b77-14dd-4a89-a22f-20a4612af305